Healthcare -
Biotechnology - NASDAQ - US
$ 9.5
0.849 %
$ 968 M
Market Cap
-1.74
P/E
NTLA - CASH FROM OPERATIONS
Cash from Operations NTLA - Intellia Therapeutics, Inc.
-394 M
LAST VALUE
-32.34%
2 YEAR CAGR
-45.11%
5 YEAR CAGR
0.00%
10 YEAR CAGR